Systemic Lupus Erythematosus Treatment Market Overview 2024: Size, Growth Drivers, and Major Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Systemic Lupus Erythematosus Treatment Market for the Period 2024 to 2033?
The market size for systemic lupus erythematosus treatment has seen speedy growth over the past few years. The projection is that it will expand from $2.76 billion in 2023 to $3.06 billion in 2024, with a compound annual growth rate (CAGR) of 10.7%. The increase in the historic period can be credited to developments in biologics and targeted therapies, enhanced comprehension of disease mechanisms, clinical studies and research initiatives, government initiatives addressing rare disease treatment, as well as rising awareness and diagnosis of lupus.
A significant increase is anticipated in the systemic lupus erythematosus treatment market in the upcoming years, with the value anticipated to reach $4.66 billion by 2028, evidencing a compound annual growth rate (CAGR) of 11.1%. The highlighted factors contributing to this growth within the projected period include the rise of biosimilars for lupus treatment, the incorporation of digital health solutions, an emphasis on complementary and alternative medicine, advances in immunomodulatory therapies, and the work of patient advocacy and support organizations. The trends to watch in the future include the development of combinatorial therapies, personalized medicine strategies, the use of biosimilars in SLE treatment, the application of telemedicine in SLE management, educational programs for patients, and international cooperation in lupus research.
Claim Your Free Sample of the Global Systemic Lupus Erythematosus Treatment Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9163&type=smp
What Factors Are Responsible for the Growth of the systemic lupus erythematosus treatment Market?
The expansion of the systemic lupus erythematosus treatment market is anticipated to be driven by the escalating count of autoimmune disorders. An autoimmune disorder is a medical condition whereby the body’s immune defense system launches an attack on itself. The immune system starts viewing parts of the body as foreign, leading to an auto-immune response where proteins known as autoantibodies are unleashed to attack healthy cells. Systemic lupus erythematosus describes an autoimmune disorder where the immune scheme attacks its tissues, sparking wide-ranging inflammation and tissue harm in the affected organs. It influences the joints, skin, brain, lungs, kidneys, and blood vessels. For example, in May 2023, the University of Oxford indicated that autoimmune disorders affect 10% of the global population, with women and men accounting for 13% and 7% respectively. Moreover, an October 2021 article by the City, University of London, stated that 4 million people in the UK, which equates to 7% of the population, are projected to have at least one autoimmune disease. There are over 80 recognized autoimmune disorders, and their incidence is growing yearly by 3–9%. Consequently, the escalating count of autoimmune disorders is catalyzing the expansion of the systemic lupus erythematosus treatment market.
Which Segments Are Important for Insight into the Systemic Lupus Erythematosus Treatment Market?
1) By Drug: Antimalarial Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Corticosteroids, Immunosuppressive Drugs
2) By Route Of Administration: Sub-Cutaneous, Oral, Intravenous
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Sales
What Are the Significant Trends Reshaping the Systemic Lupus Erythematosus Treatment Sector?
In an attempt to boost revenue in the systemic lupus erythematosus treatment market, major companies have shifted their focus towards achieving product approvals, with particular attention given to Saphnelo. This is a prescription medication taken by adults suffering from medium to severe systemic lupus erythematosus (SLE) and are under other lupus treatments. Specifically, AstraZeneca PLC, a pharmaceutical firm located in Sweden, obtained FDA approval in August 2021 for the use of anifrolumab-fnia (Saphnelo) in treating moderate to severe SLE in adults. Remarkably, this marked the first ever-approved type I interferon (type I IFN) receptor antagonist. The process that leads to lupus is heavily reliant on type I interferon (IFN), with higher type I IFN signaling levels being associated with more severe and active forms of the disease.
Order Now for Fast Delivery of Your Systemic Lupus Erythematosus Treatment Market Report!
Which Regions Are Essential for the Growth of the Systemic Lupus Erythematosus Treatment Market?
North America was the largest region in the systemic lupus erythematosus treatment market in 2023. The regions covered in the systemic lupus erythematosus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Systemic Lupus Erythematosus Treatment Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the systemic lupus erythematosus treatment market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Systemic Lupus Erythematosus Treatment Market Include
1. Systemic Lupus Erythematosus Treatment Market Executive Summary
2. Systemic Lupus Erythematosus Treatment Market Segments
3. Systemic Lupus Erythematosus Treatment Market Size And Template Market Growth Rate
4. Key Systemic Lupus Erythematosus Treatment Market Trends
5. Major Systemic Lupus Erythematosus Treatment Market Drivers
……
25. Key Mergers And Acquisitions In The Systemic Lupus Erythematosus Treatment Market
26. Top Systemic Lupus Erythematosus Treatment Companies
27. Systemic Lupus Erythematosus Treatment Market Opportunities And Strategies
28. Systemic Lupus Erythematosus Treatment Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
